TTD Donations and Controversies

ttd — IN news

A recent donation of Rs 1 crore from Chennai-based Subbarow Apparels to the Tirumala Tirupati Devasthanam (TTD) has significant implications for the organization, particularly regarding its healthcare initiatives. This contribution is aimed at enhancing medical facilities and acquiring advanced equipment for underprivileged patients through the Sri Balaji Arogya Varaprasadini scheme, which operates in conjunction with the Sri Venkateswara Institute of Medical Sciences (SVIMS).

The donation cheque was officially handed over to TTD Additional Executive Officer Ch Venkaiah Chowdary, marking a notable step in TTD’s ongoing efforts to extend its role beyond spiritual services into healthcare and social welfare programs.

However, this positive development has been overshadowed by controversies surrounding B.R. Naidu, the TTD Chairman. Bhumana Karunakar Reddy has publicly criticized Naidu’s conduct, claiming it has damaged TTD’s reputation. Reddy has called for Naidu’s immediate removal, citing accusations of misusing VIP darshan privileges for political gain.

Reddy’s remarks highlight a growing concern within TTD regarding leadership integrity, especially as the organization prepares for the upcoming Jubilee Hills Society elections on April 5. He accused former Chief Minister Chandrababu Naidu of falsely claiming credit for initiatives while sidelining officials who contributed to the projects.

The TTD’s commitment to providing top-quality medical services through SVIMS is critical, especially in light of the challenges faced by underprivileged patients. The recent donation is expected to bolster these efforts significantly.

Despite the controversies, TTD continues to strive for excellence in its healthcare services, which have become increasingly vital in the region. The FSSAI technology lab, initiated during the Y.S. Jagan Mohan Reddy government, is an example of TTD’s expanding role in healthcare.

As these events unfold, the future of TTD’s leadership and its impact on healthcare initiatives remains uncertain. Details remain unconfirmed regarding the potential ramifications of the ongoing controversies on the organization’s reputation and operations.